Sienna Biopharmaceuticals, Inc.

Sienna Biopharmaceuticals, Inc.

SNNAQ
Sienna Biopharmaceuticals, Inc.US flagOther OTC
0.00
USD
- -
- -
3,091.00Market Cap

Income Statement (USD)

APIChat
2015 Y
2016 Y
2017 Y
2018 Y
Sales/Revenue/Turnover
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- Operating Expenses
11
21
49
76
+ Selling, General & Admin
9
10
18
25
+ Research & Development
2
11
30
52
+ Other Operating Expense
- -
- -
- -
- -
Operating Income (Loss)
-11
-21
-49
-76
- Non-Operating (Income) Loss
- -
- -
2
-3
+ Interest Expense, Net
1
1
- -
- -
+ Interest Expense
1
1
- -
- -
- Interest Income
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
2
-3
Pretax Income
-11
-21
-51
-73
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
Income (Loss) from Cont Ops
-11
-21
-51
-73
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
Income (Loss) Incl. MI
-11
-21
-51
-73
- Minority Interest
- -
- -
- -
- -
Net Income, GAAP
-11
-21
-51
-73
- Preferred Dividends
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-11
-21
-51
-73
EBIT
-11
-21
-49
-76
EBITDA
-11
-21
-48
-76
EBITDA Margin (%)
- -
- -
- -
- -
EBITA
-11
-21
-49
-76
Gross Margin (%)
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
Basic Weighted Avg Shares
11
11
10
20
Basic EPS, GAAP
-0.99
-1.86
-5.19
-3.59
Basic EPS from Cont Ops
-0.99
-1.86
-5.19
-3.59
Diluted Weighted Avg Shares
11
11
10
20
Diluted EPS, GAAP
-0.99
-1.86
-5.19
-3.59
Diluted EPS from Cont Ops
-0.99
-1.86
-5.19
-3.59

Balance Sheet (USD)

APIChat
2015 Y
2016 Y
2017 Y
2018 Y
Total Current Assets
6
11
77
50
+ Cash, Cash Equivalents & STI
5
9
74
49
+ Cash & Cash Equivalents
5
9
74
49
+ ST Investments
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
+ Other ST Assets
1
1
3
2
+ Misc ST Assets
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
Total Noncurrent Assets
- -
52
60
57
+ Property, Plant & Equip, Net
- -
- -
- -
- -
+ Property, Plant & Equip
- -
- -
1
1
- Accumulated Depreciation
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
+ Other LT Assets
- -
52
59
57
+ Total Intangible Assets
- -
52
59
57
+ Goodwill
- -
10
11
11
+ Other Intangible Assets
- -
42
48
46
+ LT Deferred Tax Assets
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
Total Assets
6
62
137
107
+ Payables & Accruals
1
5
8
11
+ Accounts Payable
1
2
2
3
+ Accrued Taxes
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
+ Other Payables & Accruals
- -
3
6
8
+ ST Debt
- -
- -
- -
- -
+ ST Borrowings
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
+ Other ST Liabilities
- -
5
- -
14
+ Deferred Revenue
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Misc ST Liabilities
- -
5
- -
14
Total Current Liabilities
1
10
8
24
+ LT Debt
- -
- -
- -
30
+ LT Borrowings
- -
- -
- -
30
+ LT Finance Leases
- -
- -
- -
- -
+ Other LT Liabilities
1
30
37
26
+ Accrued Liabilities
- -
9
11
11
+ Pension Liabilities
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Misc LT Liabilities
1
21
26
16
Total Noncurrent Liabilities
1
30
37
56
Total Liabilities
2
40
46
81
+ Preferred Equity and Hybrid Capital
20
60
- -
- -
+ Share Capital & APIC
-2
-2
172
183
+ Common Stock
- -
- -
- -
- -
+ Additional Paid in Capital
-2
-2
172
183
- Treasury Stock
- -
- -
- -
- -
+ Retained Earnings
-14
-35
-86
-159
+ Other Equity
- -
- -
5
3
Equity Before Minority Interest
4
22
91
27
+ Minority/Non Controlling Interest
- -
- -
- -
- -
Total Equity
4
22
91
27
Total Liabilities & Equity
6
62
137
107
Shares Outstanding
20
20
20
21
Number of Employees
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
Net Debt
-5
-9
-74
-18
Net Debt to Equity
-122.49
-41.1
-81.65
-69.23
Tangible Common Equity Ratio
-283.26
-822.49
41.31
-59.15
Current Ratio
5.59
1.06
9.39
2.07
Cash Conversion Cycle
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChat
2015 Y
2016 Y
2017 Y
2018 Y
+ Net Income
-11
-21
-51
-73
+ Depreciation & Amortization
- -
- -
- -
- -
+ Non-Cash Items
1
1
8
8
+ Stock-Based Compensation
- -
- -
2
5
+ Deferred Income Taxes
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
+ Other Non-Cash Adj
1
1
6
4
+ Chg in Non-Cash Work Cap
- -
3
2
3
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
-1
- -
-1
1
+ Inc (Dec) in Accts Payable
1
3
3
2
+ Inc (Dec) in Other
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Operating Activities
-10
-18
-41
-62
+ Change in Fixed & Intang
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
-3
1
67
6
+ Increase in Capital Stock
- -
1
67
6
+ Decrease in Capital Stock
-3
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
-7
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
-7
- -
- -
+ Cash for JVs
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Investing Activities
- -
-7
- -
- -
+ Dividends Paid
- -
- -
- -
- -
+ Net Cash From Debt
-1
- -
4
30
+ Cash From Debt
13
- -
4
30
+ Repayments of Debt
-14
- -
- -
- -
+ Other Financing Activities
19
28
36
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Financing Activities
15
29
107
36
Effect of Foreign Exchange Rates
- -
- -
- -
- -
Net Changes in Cash
5
4
66
-26
EBITDA
-11
-21
-48
-76
EBITDA Margin (%)
- -
- -
- -
- -
Free Cash Flow
-10
-18
-41
-62
Net Cash Paid for Acquisitions
- -
7
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
Free Cash Flow to Equity
- -
21
-97
-32
Free Cash Flow per Basic Share
-0.88
-1.57
-4.24
-3.02
Price/Free Cash Flow
- -
- -
-4.34
-0.77
Cash Flow to Net Income
0.88
0.83
0.81
0.84
Capital Expenditures
- -
- -
- -
- -